- Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL Trial
- Pulsed Field Ablation of Persistent Atrial Fibrillation With Continuous ECG Monitoring Follow-Up: ADVANTAGE AF-Phase 2
- Intensive Lowering of LDL Cholesterol Levels With Evolocumab in Autoimmune or Inflammatory Diseases: An Analysis of the FOURIER Trial
- High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study
- Integrin Targeting Therapies in Pulmonary Arterial Hypertension: A Roadmap for Traversing the Translational Valley of Death?
- Evolution of TAVR as a Technology: Do Real-World Outcomes Still Support Expanded Use?
- Correction to: Neutrophil CRACR2A Promotes Neutrophil Recruitment in Sterile Inflammation and Ischemic Stroke
- Cell Painting and Machine Learning Distinguish Fibroblasts From Nonfailing and Failing Human Hearts
- Response by Jia et al to Letter Regarding Article, “Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial”
- Letter by Xu et al Regarding Article, “Effect of Delayed Remote Ischemic Preconditioning on Acute Kidney Injury and Outcomes in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial”
- Left Bundle Branch Pacing: State of the Art and Future Directions
- The Mechanism of Unequal RR Interval During Tachycardia
- Palliative Care and Advanced Cardiovascular Disease in Adults: Not Just End-of-Life Care: A Scientific Statement From the American Heart Association
- Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association
- Letter by Lu et al Regarding Article, “Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices”
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
